Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

[C-reactive protein prior to radical cystectomy: preoperative determination of CRP].

Kramer MW, Heinisch A, Wegener G, Abbas M, von Klot C, Peters I, Tezval H, Herrmann TR, Kuczyk MA, Merseburger AS.

Urologe A. 2014 Feb;53(2):222-7. doi: 10.1007/s00120-013-3299-x. German.

PMID:
23955283
2.

Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.

Gakis G, Todenhöfer T, Renninger M, Schilling D, Sievert KD, Schwentner C, Stenzl A.

BJU Int. 2011 Dec;108(11):1800-5. doi: 10.1111/j.1464-410X.2011.10234.x. Epub 2011 Apr 20.

3.

Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study.

Grimm T, Buchner A, Schneevoigt B, Kretschmer A, Apfelbeck M, Grabbert M, Jokisch JF, Stief CG, Karl A.

World J Urol. 2016 May;34(5):703-8. doi: 10.1007/s00345-015-1680-7. Epub 2015 Sep 16.

PMID:
26376992
4.

A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.

Todenhöfer T, Renninger M, Schwentner C, Stenzl A, Gakis G.

BJU Int. 2012 Dec;110(11 Pt B):E533-40. doi: 10.1111/j.1464-410X.2012.11231.x. Epub 2012 May 11.

5.

Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.

Viers BR, Boorjian SA, Frank I, Tarrell RF, Thapa P, Karnes RJ, Thompson RH, Tollefson MK.

Eur Urol. 2014 Dec;66(6):1157-64. doi: 10.1016/j.eururo.2014.02.042. Epub 2014 Feb 26.

PMID:
24630414
6.

Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.

Aziz A, Rink M, Gakis G, Kluth LA, Dechet C, Miller F, Otto W, Gierth M, Denzinger S, Schwentner C, Stenzl A, Fisch M, Burger M, Fritsche HM.

Urol Int. 2014;93(3):352-60. doi: 10.1159/000362248. Epub 2014 Aug 19.

PMID:
25138778
7.

Can neutrophil-lymphocyte ratio and lymph node density be used as prognostic factors in patients undergoing radical cystectomy?

Demirtaş A, Sabur V, Akınsal EC, Demirci D, Ekmekcioglu O, Gulmez I, Tatlisen A.

ScientificWorldJournal. 2013 Mar 31;2013:703579. doi: 10.1155/2013/703579. Print 2013.

8.

Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy.

Gondo T, Nakashima J, Ohno Y, Choichiro O, Horiguchi Y, Namiki K, Yoshioka K, Ohori M, Hatano T, Tachibana M.

Urology. 2012 May;79(5):1085-91. doi: 10.1016/j.urology.2011.11.070. Epub 2012 Mar 23.

PMID:
22446338
9.

NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder.

Potretzke A, Hillman L, Wong K, Shi F, Brower R, Mai S, Cetnar JP, Abel EJ, Downs TM.

Urol Oncol. 2014 Jul;32(5):631-6. doi: 10.1016/j.urolonc.2013.12.009. Epub 2014 Mar 12.

PMID:
24629498
10.

C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.

Obata J, Kikuchi E, Tanaka N, Matsumoto K, Hayakawa N, Ide H, Miyajima A, Nakagawa K, Oya M.

Urol Oncol. 2013 Nov;31(8):1725-30. doi: 10.1016/j.urolonc.2012.05.008. Epub 2012 Nov 8.

PMID:
23141922
11.

Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.

Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW.

J Urol. 2007 Dec;178(6):2308-12; discussion 2313. Epub 2007 Oct 22.

PMID:
17936804
12.

Prognostic impact of preoperative hematological disorders and a risk stratification model in bladder cancer patients treated with radical cystectomy.

Sejima T, Morizane S, Yao A, Isoyama T, Saito M, Amisaki T, Koumi T, Takenaka A.

Int J Urol. 2014 Jan;21(1):52-7. doi: 10.1111/iju.12161. Epub 2013 May 27.

13.

The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.

Gershman B, Moreira DM, Tollefson MK, Frank I, Cheville JC, Thapa P, Tarrell RF, Thompson RH, Boorjian SA.

Urol Oncol. 2016 Jan;34(1):4.e1-9. doi: 10.1016/j.urolonc.2015.07.023. Epub 2015 Aug 29.

PMID:
26329815
14.

[Clinical analysis of bladder cancer patients undergoing radical cystectomy].

Kato Y, Hasegawa Y, Wakita T, Hayashi N.

Hinyokika Kiyo. 2005 Nov;51(11):719-25. Japanese.

16.

C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy.

Yoshida S, Saito K, Koga F, Yokoyama M, Kageyama Y, Masuda H, Kobayashi T, Kawakami S, Kihara K.

BJU Int. 2008 Apr;101(8):978-81. doi: 10.1111/j.1464-410X.2007.07408.x. Epub 2008 Jan 10.

17.

Risk stratification model, including preoperative serum C-reactive protein and estimated glomerular filtration rate levels, in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy.

Morizane S, Yumioka T, Yamaguchi N, Masago T, Honda M, Sejima T, Takenaka A.

Int Urol Nephrol. 2015 Aug;47(8):1335-41. doi: 10.1007/s11255-015-1033-x. Epub 2015 Jun 24.

PMID:
26104379
18.

A novel risk stratification model, involving preoperative lymphocyte-monocyte ratio and standard pathological factors, for overall survival in patients with bladder cancer undergoing radical cystectomy.

Yoshida T, Kinoshita H, Yoshida K, Yanishi M, Inui H, Komai Y, Sugi M, Inoue T, Murota T, Matsuda T.

Jpn J Clin Oncol. 2015 Dec;45(12):1162-7. doi: 10.1093/jjco/hyv146. Epub 2015 Sep 29.

PMID:
26423342
19.

Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.

Fujita K, Inamoto T, Yamamoto Y, Tanigawa G, Nakayama M, Mori N, Tsujihata M, Azuma H, Nonomura N, Uemura M.

Int J Urol. 2015 Nov;22(11):1006-12. doi: 10.1111/iju.12868. Epub 2015 Jul 7.

20.

External validation of extranodal extension and lymph node density as predictors of survival in node-positive bladder cancer after radical cystectomy.

Masson-Lecomte A, Vordos D, Hoznek A, Yiou R, Allory Y, Abbou CC, de la Taille A, Salomon L.

Ann Surg Oncol. 2013 Apr;20(4):1389-94. doi: 10.1245/s10434-012-2753-0. Epub 2012 Dec 4.

PMID:
23208127

Supplemental Content

Support Center